The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CALGB/ECOG 100104 (Alliance) study: Lenalidomide (LEN) vs placebo (PBO) maintenance (maint) after stem cell transplant (SCT) for patients (pts) with multiple myeloma—Overall survival (OS) and progression-free survival (PFS) adjusted for treatment (tx) crossover (XO).
 
Philip L. McCarthy
Honoraria - Bristol-Myers Squibb; Celgene; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Karyopharm Therapeutics; Sanofi; Takeda
Research Funding - Celgene
 
Sarah A. Holstein
Consulting or Advisory Role - Celgene; Onyx
Travel, Accommodations, Expenses - Celgene; Onyx
 
Sin-Ho Jung
No Relationships to Disclose
 
Miranda Cooper
Employment - BresMed
Consulting or Advisory Role - Celgene (Inst)
Research Funding - Celgene (Inst)
 
Craig J Gibson
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Edward Allen Stadtmauer
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda; Teva
 
Benjamin Winograd
Employment - Celgene
 
Paul G. Richardson
Consulting or Advisory Role - Genmab
Research Funding - Celgene; Millennium